Iressa gefitinib: Preliminary Phase III data

In the double-blind, international Phase III ISEL trial (Study 709), Iressa gefitinib

Read the full 122 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE